Ziyad S. Almalki

1.2k total citations · 1 hit paper
85 papers, 718 citations indexed

About

Ziyad S. Almalki is a scholar working on Epidemiology, Economics and Econometrics and Geriatrics and Gerontology. According to data from OpenAlex, Ziyad S. Almalki has authored 85 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 17 papers in Economics and Econometrics and 15 papers in Geriatrics and Gerontology. Recurrent topics in Ziyad S. Almalki's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Chronic Disease Management Strategies (9 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Ziyad S. Almalki is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Chronic Disease Management Strategies (9 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Ziyad S. Almalki collaborates with scholars based in Saudi Arabia, United States and Pakistan. Ziyad S. Almalki's co-authors include Jeff J. Guo, Abdullah K. Alahmari, Nehad J. Ahmed, Ahmed M. Alshehri, Abdullah Salah Alanazi, Abdulaziz Ibrahim Alzarea, Ahmed A. Albassam, Mohamed Balaha, Usa Chaikledkaew and Sermsiri Sangroongruangsri and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and International Journal of Obesity.

In The Last Decade

Ziyad S. Almalki

78 papers receiving 706 citations

Hit Papers

Economic costs of obesity: a systematic review 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Economic costs of obesity: a systematic review
    2023 60 citations Sermsiri Sangroongruangsri, Usa Chaikledkaew et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziyad S. Almalki Saudi Arabia 15 95 93 83 82 77 85 718
Dyah Aryani Perwitasari Indonesia 17 105 1.1× 129 1.4× 66 0.8× 82 1.0× 183 2.4× 166 962
Shouzhen Cheng China 16 64 0.7× 86 0.9× 38 0.5× 122 1.5× 88 1.1× 27 807
Vincent D. Marshall United States 18 46 0.5× 114 1.2× 57 0.7× 107 1.3× 121 1.6× 62 802
Javier Gómez‐Pavón Spain 15 163 1.7× 65 0.7× 46 0.6× 84 1.0× 66 0.9× 74 645
Firomsa Bekele Ethiopia 15 133 1.4× 86 0.9× 71 0.9× 47 0.6× 106 1.4× 61 751
Kate Traynor United States 13 70 0.7× 112 1.2× 100 1.2× 145 1.8× 102 1.3× 422 1.1k
Treasure McGuire Australia 17 77 0.8× 113 1.2× 45 0.5× 112 1.4× 143 1.9× 87 845
Rashmi Sharma India 15 82 0.9× 76 0.8× 55 0.7× 216 2.6× 98 1.3× 63 881
Farida Islahudin Malaysia 15 72 0.8× 93 1.0× 52 0.6× 75 0.9× 114 1.5× 77 772
Rosa Morros Spain 15 58 0.6× 53 0.6× 91 1.1× 82 1.0× 209 2.7× 80 973

Countries citing papers authored by Ziyad S. Almalki

Since Specialization
Citations

This map shows the geographic impact of Ziyad S. Almalki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyad S. Almalki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyad S. Almalki more than expected).

Fields of papers citing papers by Ziyad S. Almalki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyad S. Almalki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyad S. Almalki. The network helps show where Ziyad S. Almalki may publish in the future.

Co-authorship network of co-authors of Ziyad S. Almalki

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyad S. Almalki. A scholar is included among the top collaborators of Ziyad S. Almalki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyad S. Almalki. Ziyad S. Almalki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almalki, Ziyad S., et al.. (2025). Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model. ClinicoEconomics and Outcomes Research. Volume 17. 217–232. 1 indexed citations
2.
Alotaibi, Mazyad, Mansour Abdullah Alshehri, Ziyad S. Almalki, et al.. (2025). The role of fMRI in the mind decoding process in adults: a systematic review. PeerJ. 13. e18795–e18795.
3.
4.
Almalki, Ziyad S., et al.. (2025). The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study. ClinicoEconomics and Outcomes Research. Volume 17. 233–246. 1 indexed citations
5.
Alshehri, Abdullah H., et al.. (2024). HSD1 Assessing Community Pharmacist Expectation, Satisfaction, and Intentions in the Wasfaty E-Service: Using the Expectation Conformation Theory. Value in Health. 27(6). S221–S221. 1 indexed citations
6.
Alzarea, Abdulaziz Ibrahim, Yusra Habib Khan, Sami I. Alzarea, et al.. (2024). Assessment of Health-Related Quality of Life Among Patients with Chronic Diseases and Its Relationship with Multimorbidity: A Cross-Sectional Study from Saudi Arabia. Patient Preference and Adherence. Volume 18. 1077–1094. 4 indexed citations
7.
Ahmad, Niyaz, et al.. (2023). Preparation of Melatonin Nanoparticles and their Enhancement of Lungs Bioavailability in the Treatment of Lungs Cancer. Journal of Young Pharmacists. 15(2). 314–325. 2 indexed citations
8.
9.
Ahmed, Nehad J., Ziyad S. Almalki, Saeed M. Alshahrani, et al.. (2023). Knowledge, Perceptions, and Readiness of Telepharmacy among Hospital Pharmacists in Saudi Arabia. Healthcare. 11(8). 1087–1087. 12 indexed citations
10.
Singh, N.B., Richa Tomar, Mohammad Tarique Imam, et al.. (2023). Dose-dependent cytotoxicity against lung cancer cells via green synthesized ZnFe 2 O 4 /cellulose nanocomposites. e-Polymers. 23(1). 2 indexed citations
11.
Alavudeen, Sirajudeen Shaik, Vigneshwaran Easwaran, Noohu Abdulla Khan, et al.. (2023). Cardiovascular Disease-Related Health Promotion and Prevention Services by Pharmacists in Saudi Arabia: How Well Are They Prepared?. Healthcare. 11(11). 1614–1614. 1 indexed citations
12.
Sharma, Arun Kumar, Akash Sharma, Akash Sharma, et al.. (2023). Dysbiosis versus diabesity: Pathological signaling and promising therapeutic strategies. Drug Discovery Today. 28(5). 103558–103558. 8 indexed citations
13.
Alshammari, Thamir M., et al.. (2023). Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health. Saudi Pharmaceutical Journal. 31(6). 1029–1035. 8 indexed citations
14.
15.
Malkin, Jesse D., Drishti Baid, Reem F. Alsukait, et al.. (2022). The economic burden of overweight and obesity in Saudi Arabia. PLoS ONE. 17(3). e0264993–e0264993. 30 indexed citations
16.
Ahmed, Nehad J., Ziyad S. Almalki, Ahmed M. Alshehri, et al.. (2022). Implementing an Antimicrobial Stewardship Programme to Improve Adherence to a Perioperative Prophylaxis Guideline. Healthcare. 10(3). 464–464. 8 indexed citations
17.
Almalki, Ziyad S., Abdullah K. Alahmari, Ahmed M. Alshehri, et al.. (2022). Investigating households’ out-of-pocket healthcare expenditures based on number of chronic conditions in Riyadh, Saudi Arabia: a cross-sectional study using quantile regression approach. BMJ Open. 12(9). e066145–e066145. 8 indexed citations
18.
Almalki, Ziyad S., et al.. (2021). Evaluation of medication error rates in Saudi Arabia. Medicine. 100(9). e24956–e24956. 25 indexed citations
19.
Iqbal, Muhammad Shahid, Yaman Walid Kassab, Fahad Alsaikhan, et al.. (2020). Assessing quality of life using WHOQOL-BREF: A cross-sectional insight among patients on warfarin in Malaysia. Saudi Pharmaceutical Journal. 28(8). 936–942. 7 indexed citations
20.
Almalki, Ziyad S., et al.. (2020). Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus. Value in Health Regional Issues. 21. 157–163. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dyah Aryani Perwitasari Breakdown of academic impact, for papers by Shouzhen Cheng Breakdown of academic impact, for papers by Vincent D. Marshall Breakdown of academic impact, for papers by Javier Gómez‐Pavón Breakdown of academic impact, for papers by Firomsa Bekele Breakdown of academic impact, for papers by Kate Traynor Breakdown of academic impact, for papers by Treasure McGuire Breakdown of academic impact, for papers by Rashmi Sharma Breakdown of academic impact, for papers by Farida Islahudin Breakdown of academic impact, for papers by Rosa Morros
Rankless by CCL
2026